| |
| |
|
| Insider
Information: |
Lasowski Juergen |
| Relationship: |
EVP, Corp. Dev & Strat... |
| City: |
Salt Lake City |
| State: |
UT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
20,220 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
20,220 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
NPS Pharmaceuticals Inc |
NPSP |
Senior VP Business Dev... |
2006-06-14 |
20,220 |
2006-05-10 |
0 |
Premium* |
|
|
Onyx Pharmaceuticals Inc |
ONXX |
EVP, Corp. Dev & Strat... |
2013-10-01 |
0 |
2008-11-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corp. Dev & Strategy |
• – – |
2013-10-01 |
4 |
D |
$125.00 |
$3,781,250 |
D/D |
(30,250) |
0 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corp. Dev & Strategy |
• – – |
2013-10-01 |
4 |
D |
$125.00 |
$229,125 |
D/D |
(1,833) |
30,250 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corp. Dev & Strategy |
• – – |
2013-07-01 |
4 |
AS |
$132.63 |
$3,365,486 |
D/D |
(25,375) |
32,083 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corp. Dev & Strategy |
• – – |
2013-07-01 |
4 |
OE |
$28.55 |
$724,456 |
D/D |
25,375 |
57,458 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corp. Dev & Strategy |
• – – |
2013-05-14 |
4 |
S |
$96.38 |
$403,967 |
D/D |
(4,182) |
32,083 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corp. Dev & Strategy |
• – – |
2013-04-01 |
4 |
AS |
$86.13 |
$228,350 |
D/D |
(2,651) |
36,265 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corp. Dev & Strategy |
• – – |
2013-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,100 |
38,916 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corp. Dev & Strategy |
• – – |
2012-10-05 |
4 |
AS |
$90.00 |
$531,180 |
D/D |
(5,902) |
31,816 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corporate Development |
• – – |
2012-07-25 |
4 |
AS |
$73.97 |
$395,601 |
D/D |
(5,348) |
48,968 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corporate Development |
• – – |
2012-07-02 |
4 |
D |
$66.62 |
$1,184,367 |
D/D |
(17,626) |
54,316 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corporate Development |
• – – |
2012-07-02 |
4 |
OE |
$28.55 |
$399,700 |
D/D |
14,000 |
71,942 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corporate Development |
• – – |
2012-04-02 |
4 |
D |
$36.58 |
$80,762 |
D/D |
(2,208) |
57,942 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corporate Development |
• – – |
2012-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
26,150 |
60,150 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corporate Development |
• – – |
2011-09-01 |
4 |
AS |
$34.14 |
$34,345 |
D/D |
(1,006) |
35,232 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corporate Development |
• – – |
2011-08-01 |
4 |
AS |
$33.27 |
$55,395 |
D/D |
(1,665) |
36,238 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corporate Development |
• – – |
2011-05-20 |
4 |
AS |
$43.02 |
$25,555 |
D/D |
(594) |
37,238 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corporate Development |
• – – |
2011-05-06 |
4 |
AS |
$40.00 |
$151,320 |
D/D |
(3,783) |
37,832 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corporate Development |
• – – |
2011-04-01 |
4 |
AS |
$35.02 |
$51,760 |
D/D |
(1,478) |
41,615 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, Corporate Development |
• – – |
2011-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
43,093 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
SVP, Corporate Development |
• – – |
2010-05-20 |
4 |
AS |
$24.06 |
$14,439 |
D/D |
(600) |
13,861 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
SVP, Corporate Development |
• – – |
2010-04-01 |
4 |
AS |
$30.10 |
$22,244 |
D/D |
(739) |
14,461 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
SVP, Corporate Development |
• – – |
2010-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
15,200 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
SVP, Corporate Development |
• – – |
2009-08-14 |
4 |
AS |
$30.73 |
$97,783 |
D/D |
(3,182) |
9,200 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
SVP, Corporate Development |
• – – |
2009-07-22 |
4 |
AS |
$35.90 |
$317,642 |
D/D |
(8,828) |
12,382 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
SVP, Corporate Development |
• – – |
2009-06-26 |
4 |
AS |
$26.27 |
$87,533 |
D/D |
(3,332) |
21,210 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
